The future of comprehensive cardiovascular risk prediction using CCTA | SCCT Edinburgh 2023

Read more

December 2022
Inflammation as a new target in CV risk reduction
“Lowering LCL-c is the first, second and third thing we have to do to lower atherosclerotic event rates, but what…
Read more

July 2022
SCCT Symposium : Visualising Coronary Inflammation in CCTA: The Next Frontier for Cardiovascular Risk Prediction
Coronary Inflammation and Cardiovascular Disease Prevention View here